 |
 |
LOL! I didn't even see that! I think you are right Kathleen ;-) Nic On Wed, Jul 22, 2009 at 10:02 AM, Kathleen Cochran <[log in to unmask]>wrote: > "Memorial Sloan Kettering Cancer Center > 1275 York Ave. > Unfledged York, NY 10021 > Common States" > > Looks like they used some kind of translation program, maybe? > > Kathleen > > 2009/7/22 Nic Marais <[log in to unmask]> > > > OMG! > > > > "The late study shows that therapeutic cloning can take up Parkinson's > > disease in a mouse follow." > > > > "While this current business is in animals, it could have future > > implications as this method may be an effective habit to reduce > transplant > > rejection and heighten recapture in other diseases and in other organ > > systems." > > > > (To quote only some of numerous examples;-) > > > > But who cares about the Japenglish of their reports. As long as they > carry > > on with the good work! > > > > Nic 57/15 > > > > > > On Wed, Jul 22, 2009 at 7:12 AM, rayilynlee <[log in to unmask]> wrote: > > > > > Therapeutic Cloning Treats Parkinson's Disease In Mice > > > July 20, 2009 > > > Research led by investigators at Statue Sloan-Kettering Cancer Center > > > (MSKCC) has shown that salutary cloning, also known as somatic-cell > > nuclear > > > transfer (SCNT), can be used to expound on Parkinson's disease in mice. > > The > > > study's results are published in the Procession 23 online number of the > > > minutes Nature Drug. > > > > > > For the principal term, researchers showed that health-giving cloning > or > > > SCNT has been successfully used to study disease in the selfsame > subjects > > > from whom the endorse cells were derived. While this current business > is > > in > > > animals, it could have future implications as this method may be an > > > effective habit to reduce transplant rejection and heighten recapture > in > > > other diseases and in other organ systems. > > > > > > In therapeutic cloning or SCNT, the focus of a somatic cell from a > donor > > > subject is inserted into an egg from which the heart has been removed. > > This > > > cell then develops into a blastocyst from which embryonic stem cells > can > > be > > > harvested and differentiated for corrective purposes. As the genetic > dirt > > in > > > the resulting staunch cells comes from the donor subject, healthy > cloning > > or > > > SCNT would yield obedient to-unique to cells that are spared by the > > > invulnerable system after transplantation. > > > > > > The late study shows that therapeutic cloning can take up Parkinson's > > > disease in a mouse follow. The scientists used skin cells from the tail > > of > > > the creature to fashion customized or autologous dopamine neurons the > > > missing neurons in Parkinson's disease. The mice that received neurons > > > derived from one at a time matched stem cell lines exhibited > neurological > > > recovery. But when these neurons were grafted into mice that did not > > > genetically match the transplanted cells, the cells did not survive > well > > and > > > the mice did not recover. > > > > > > The work was led by higher- ranking author Lorenz Studer, MD, Head of > the > > > Shoot Stall and Tumor Biology Laboratory within the Sloan-Kettering > Begin > > at > > > MSKCC, and get up to author Viviane Tabar, MD, Neurosurgeon and control > > room > > > scientist at MSKCC. The work was performed in collaboration with > > scientists > > > at the Riken Alliance in Kobe, Japan. > > > > > > Other MSKCC researchers who contributed to this study are: Mark > > Tomishima, > > > Georgia Panagiotakos, George Al-Shamy, Bill Chan, and Jayanthi Menon. > > > Scientists in Japan include group leader Teruhiko Wakayama and > scientists > > > Eiji Mizutani, Sayaka Wakayama and Hiroshi Ohta. This research was > > supported > > > by the US National Institute of Neurological Disorders and Strike, the > > Starr > > > Tri-institutional Stem Chamber Initiative, the Michael J. Fox > Foundation > > > seeking Parkinson's Research, the Michael W. McCarthy Fundamental > > principle > > > and an unrestricted grant from the Kinetics Understructure. > > > > > > Memorial Sloan Kettering Cancer Center > > > 1275 York Ave. > > > Unfledged York, NY 10021 > > > Common States > > > http://www.mskcc.org > > > > > > Rayilyn Brown > > > Director AZNPF > > > Arizona Chapter National Parkinson Foundation > > > [log in to unmask] > > > ---------------------------------------------------------------------- > > > To sign-off Parkinsn send a message to: mailto: > > > [log in to unmask] > > > In the body of the message put: signoff parkinsn > > > > > > > ---------------------------------------------------------------------- > > To sign-off Parkinsn send a message to: mailto: > > [log in to unmask] > > In the body of the message put: signoff parkinsn > > > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto: > [log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn